Opioid Antagonists and Overdose Reversal Therapeutics
Commercial sector
Opioid Antagonists and Overdose Reversal Therapeutics
Companies developing or manufacturing reversal agents for ultrapotent synthetic opioids (fentanyl analogues, carfentanil) and incapacitating agents, including high-dose and long-acting opioid antagonists (naloxone, nalmefene), opioid-sequestering antibodies, and respiratory stimulants for opioid-induced respiratory depression.
Companies7
Commercial products14
Technology classes2
Countries1
Patents175
Profiled companies
Products
- Emergent BioSolutionsUnited States2
- Cessation TherapeuticsUnited States–
- Elysium TherapeuticsUnited States5
- TMT-Rx (Torralva Medical Therapeutics)United States1
- ARMR Sciences, Inc.United States1
- Clear Scientific, Inc.United States–
+ 1 more